Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
04/1995
04/13/1995WO1995009655A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines
04/13/1995WO1995009654A1 Gene therapy of the nervous system
04/13/1995WO1995009640A1 Methods for analysis of human stem cells
04/13/1995WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy
04/13/1995CA2173726A1 Methods for analysis of human stem cells
04/13/1995CA2173495A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines
04/13/1995CA2171109A1 Gene therapy of the nervous system
04/12/1995EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix
04/06/1995WO1995009241A2 Anti-cancer gene therapy by modulation of immune or inflammatory response
04/06/1995WO1995009236A1 USING ANTISENSE OLIGONUCLEOTIDES TO MODULATE NERVE GROWTH AND TO REVERSE β/A4 AMYLOID-INDUCED MORPHOLOGY
04/06/1995WO1995009011A1 Methods of stimulating phagocytosis
04/06/1995WO1995009010A1 Arteriosclerosis remedy
04/06/1995WO1995009009A1 Polyamino acid oligonucleotide carrier
04/06/1995WO1995009002A1 Methods of inhibiting phagocytosis
04/06/1995WO1995006744A3 Methods of suppressing immune response by gene therapy
04/06/1995WO1995006718A3 Methods of suppressing autoimmune response
04/06/1995WO1995006717A3 Methods of suppressing graft rejection
04/06/1995CA2172978A1 Arteriosclerosis remedy
04/06/1995CA2172393A1 Methods of stimulating phagocytosis
04/06/1995CA2171553A1 Using antisense oligonucleotides to modulate nerve growth and to reverse .beta./a4 amyloid-induced morphology
04/05/1995EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host
04/05/1995EP0646171A1 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes
04/05/1995EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE
04/05/1995EP0646010A1 Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression
04/05/1995EP0513161B1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
03/1995
03/30/1995WO1995008635A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
03/30/1995WO1995008631A2 Target antigens of transmission blocking antibodies for malaria parasites
03/30/1995WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995WO1995008622A1 Recombinant infectious laryngotracheitis virus and uses thereof
03/30/1995WO1995008554A1 Nf-at polypeptides and polynucleotides
03/30/1995WO1995008350A1 REGULATION OF bcl-2 GENE EXPRESSION
03/30/1995WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
03/30/1995CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995CA2172387A1 Recombinant infectious laryngotracheitis virus and uses thereof
03/30/1995CA2172287A1 Nf-at polypeptides and polynucleotides
03/30/1995CA2172073A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
03/29/1995EP0644944A1 Adeno-associated virus with inverted terminal repeat sequences as promoter
03/29/1995EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof
03/29/1995EP0644933A1 Constitutive and inducible epidermal vector systems
03/29/1995EP0644929A1 System and method for transplantation of cells
03/29/1995EP0644889A1 COMPOSITIONS AND METHODS FOR MODULATING $g(b)-AMYLOID
03/29/1995EP0644765A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
03/29/1995EP0332667B1 Vector for integration site independent gene expression in mammalian host cells
03/28/1995CA2108401A1 Receptor induced by lymphocyte activation in imflammatory response
03/23/1995WO1995007995A2 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995WO1995007994A2 Recombinant alphavirus vectors
03/23/1995WO1995007981A1 Grb3-3 gene, variants and uses thereof
03/23/1995WO1995007923A1 Multi-unit ribozyme inhibition of oncogene expression
03/23/1995WO1995007922A1 Drug binding protein
03/23/1995WO1995007718A2 Purine nucleoside phosphorylase gene therapy for human malignancy
03/23/1995WO1995007711A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide
03/23/1995WO1994029469A3 Plasmids suitable for gene therapy
03/23/1995CA2171318A1 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995CA2169938A1 Grb3-3 gene; variants and uses thereof
03/21/1995US5399493 Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
03/21/1995US5399346 Gene therapy
03/16/1995WO1995007105A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response
03/16/1995WO1995007073A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
03/16/1995WO1995003328A3 Melanoma-inhibiting protein
03/16/1995WO1995002420A3 Prodrugs of protein tyrosine kinase inhibitors
03/16/1995CA2171211A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response
03/15/1995EP0642761A1 Method of quantitative determination of bone salt with ct equipment
03/15/1995EP0642591A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
03/15/1995EP0642589A1 Method and reagent for inhibiting viral replication
03/15/1995EP0642584A1 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors
03/09/1995WO1995006745A1 Vector for gene therapy of the liver
03/09/1995WO1995006744A2 Methods of suppressing immune response by gene therapy
03/09/1995WO1995006734A1 Cloning of a member of the serine-threonine-kinase family
03/09/1995WO1995006718A2 Methods of suppressing autoimmune response
03/09/1995WO1995006717A2 Methods of suppressing graft rejection
03/09/1995WO1995006661A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
03/09/1995WO1995006657A1 Interleukin-10 and immunosuppression
03/09/1995WO1995006486A1 Treatment of human tumors by genetic transformation of human tumor cells
03/09/1995WO1995006474A1 Thiol-derivatized nucleosides and oligonucleosides
03/09/1995WO1995006456A1 METHODS AND COMPOSITIONS FOR BINDING TAU AND MAP2c PROTEINS
03/09/1995WO1995006415A1 Senescent cell-derived inhibitors of dna synthesis
03/09/1995WO1995006411A1 Method and composition for weight reduction
03/09/1995WO1995006409A1 Genetically modified human hematopoietic stem cells and their progeny
03/09/1995CA2170980A1 Genetically modified human hematopoietic stem cells and their progeny
03/09/1995CA2170882A1 Vector for gene therapy of the liver
03/09/1995CA2170727A1 Methods and compositions for binding tau and map2c proteins
03/09/1995CA2170393A1 Cloning of a member of the serine-threonine-kinase family
03/09/1995CA2169557A1 Treatment of human tumors by genetic transformation of human tumor cells
03/09/1995CA2158934A1 Methods of suppressing immune response by gene therapy
03/09/1995CA2158933A1 Methods of suppressing graft rejection
03/09/1995CA2158932A1 Methods of suppressing autoimmune response
03/08/1995EP0641220A1 Methods and agents for modulating immune response, and uses thereof
03/08/1995EP0641212A1 Method and reagent for inhibiting cancer development
03/02/1995WO1995006120A1 Recombinant cells from the monocyte-macrophage cell line for gene therapy
03/02/1995WO1995005853A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
03/02/1995WO1995005851A1 HIV vif-RELATED COMPOSITIONS, AND PROPHYLACTIC AND THERAPEUTIC USES THEREOF
03/02/1995WO1995005847A1 Accessory factor function for interferon gamma and its receptor
03/02/1995WO1995005843A1 Method for producing a highly enriched population of hematopoietic stem cells
03/02/1995WO1995005835A1 Gene therapy for solid tumors, papillomas and warts
03/02/1995WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/02/1995WO1995005750A1 Cell death regulator
03/02/1995WO1995005738A1 Anticancer agents and apoptosis
03/02/1995WO1994025601A3 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/02/1995DE4425481A1 Melanoma-inhibiting protein
03/02/1995DE4407859C1 Vector for liver-specific gene therapy
1 ... 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 ... 870